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Here, we report the draft genome sequence of Mycobacterium brumae type strain ATCC 51384. This is the first draft genome sequence
of M. brumae, a nonpathogenic, rapidly growing, nonchromogenic mycobacterium, with immunotherapeutic capacities.
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Mycobacterium brumae is an environmental mycobacteriumthat was described for the first time in 1993 when it was
isolated from water and soil samples and from a human sputum of
an asymptomatic individual (1). Colonies on agar media are eu-
gonic, rough, and nonpigmented. Growth occurs within 5 days at
30°C and 37°C. In liquid medium, M. brumae forms clumps with
cording morphology (2). The cell wall of M. brumae contains only
-mycolic acids, which only release docosanoate after pyrolysis
(1). Until now, no attention has been paid to this mycobacterium
species, because no cases of infection due to M. brumae have been
described in animals or humans. In 2004, Han et al. reported a
catheter-infection case related to this species (2), but it was later
confirmed that the isolate strain was not M. brumae (3).
We recently demonstrated the antitumor and immunomodu-
latory activity of this mycobacterium (4, 5). In vitro studies have
shown the capacity of M. brumae to activate macrophages. M. bru-
mae is able to inhibit the proliferation of bladder cancer cells, with
a higher growth inhibition capacity than M. bovis BCG in low-
grade bladder tumor cells (4). M. brumae triggers an antitumor
profile in ex vivo infected peripheral blood cells, and in vivo studies
have demonstrated that both live and -irradiated M. brumae are
able to prolong survival of tumor-bearing mice (4, 5). Due to the
interest in finding the antigen(s) responsible for these activities,
we aimed to sequence the M. brumae genome.
M. brumae ATCC 51384 was grown on Middlebrook 7H10
medium for 1 week. Cells were scraped, and genomic DNA was
isolated using the Ultra-Clean microbial DNA isolation kit (MO
BIO Laboratories, Inc.) according to the manufacturer’s specifi-
cations. We sequenced the genomic DNA on an Illumina MiSeq
system and assembled the reads using MIRA (6), with manual
correction assisted by the STADEN package (7). A total of
3,784,633 reads were used after quality assessment and trimming,
with an average read length of 361.98 bp (SD  98.58). The as-
sembled sequences of M. brumae comprised 75 contigs larger than
1.5 kb, with a combined length of 4,026,006 bp and a mean G-C
ratio of 69.1%. The average and median contig sizes were 53,680
and 27,753 bp, respectively, and the longest contig was 572,857 bp.
The number of predicted protein coding genes is 3,823 after RAST
prediction of open reading frames (8). Average nucleotide com-
parison with all draft, complete, and some selected Sequence Read
Archive mycobacterial genomes (April 2015, n  110) corrobo-
rated that M. brumae forms a distinct and separate species with a
minimum of 70.31% (Mycobacterium abscessus M94) and a max-
imum of 76.53% nucleotide identity (Mycobacterium avium
subsp. paratuberculosis S5) with the rest of the mycobacteria spe-
cies analyzed.
In conclusion, we report the genome sequence of M. brumae
ATCC 51384 that to the best of our knowledge is the first genome
sequence of this species.
Nucleotide sequence accession numbers. This whole-genome
shotgun project has been deposited in European Nucleotide Ar-
chive (ENA) (http://www.ebi.ac.uk/ena) under the accession
numbers FJNX00000001 to FJNX00000075. The versions de-
scribed in this paper are the first versions, FJNX01000001 to
FJNX01000075.
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